EUVIMEDEUVIMED entdecken
Crossref

Selecting the best-value biosimilar in emerging countries

Gilberto Castañeda-Hernández

Exploration of Musculoskeletal Diseases · 14.09.2024 · 423-430

DOI: 10.37349/emd.2024.00067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Exploration of Musculoskeletal Diseases, online erschienen am 14.09.2024. Verfasst von Gilberto Castañeda-Hernández. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of biosimilars is to alleviate the financial burden of biological medicinal products. A most relevant challenge for emerging countries is how to select the best option available. In most cases, price is the major determinant, as budgets are chronically scarce. However, initial savings due to price reductions can be overridden if there is a lack of supply due to product shortages or withdrawals. These events can be prevented by a best-value strategy. According to the concept of best-value medicinal products, price is only one of the various criteria to be considered. The purpose of the present paper is to provide suggestions of criteria that can be useful for selecting the best-value biological in emerging countries. Six criteria, that are not limitative, have been selected as follows: standards of regulatory approval, quality of the product, good distribution practices, security of supply, pharmacovigilance, and price.

Zitieren

APA

Castañeda-Hernández, G. (2024). Selecting the best-value biosimilar in emerging countries. Exploration of Musculoskeletal Diseases, 423-430. https://doi.org/10.37349/emd.2024.00067

Vancouver

Castañeda-Hernández G. Selecting the best-value biosimilar in emerging countries. Exploration of Musculoskeletal Diseases. 2024:423-430. doi:10.37349/emd.2024.00067

BibTeX
@article{CastaedaHernndez2024,
  author = {Castañeda-Hernández, Gilberto},
  title = {Selecting the best-value biosimilar in emerging countries},
  journal = {Exploration of Musculoskeletal Diseases},
  year = {2024},
  pages = {423--430},
  doi = {10.37349/emd.2024.00067}
}
Kostenlos starten →